Artemis Hospital, Gurgaon – India
About Dr. Lalit Kumar
Padma Shri Awardee, Dr. Lalit Kumar is a highly respected and leading oncologist in India, renowned for his visionary contributions to medical oncology and stem cell transplantation. With over 35 years of extensive experience, he has made significant advancements in treating haematological and gynaecological cancers. Dr. Kumar is particularly recognised for pioneering cost-effective treatment protocols for bone marrow and stem cell transplants, making advanced cancer care more accessible. He has also served as Professor and Head (Medical Oncology) at AIIMS, New Delhi for several years. His commitment to innovative cancer treatment continues to profoundly impact patient outcomes both nationally and internationally. He is renowned to have developed most affordable treatment protocols for stem cell transplantations and sustained bone marrow.He is undoubtedly one of the top medical oncologists in India.
Medical Degrees:
- MBBS – Sarojini Naidu Medical College, Agra
- MD (Medicine) – Sarojini Naidu Medical College, Agra
- DM Medical Oncology – Adyar Cancer Institute, Chennai
Fellowships & Special Training:
- Post-Doctoral Fellowship – Royal Postgraduate Medical School of the Hammersmith Hospital, London
- Fulbright Scholarship – United States of America
- Advanced training in bone marrow transplantation and stem cell therapy
Certifications & Accreditations:
- Fellowship: Indian Academy of Sciences (FASc)
- Fellowship: National Academy of Medical Sciences of India (FAMS)
- Fellowship: National Academy of Sciences (FNASI)
- Member of Expert Committee to examine the Serious Adverse Events (SAE) of deaths occurring during clinical trials
- Indo British Health Initiative (IBHI)
- Institute of Women's Health, University College London (IFWH, UCL)
Major Cancer Types Treated:
- Acute Lymphoblastic Leukaemia
- Acute Myeloid Leukaemia
- Blood Cancer
- Chronic Myeloid Leukaemia
- Chronic Lymphocytic Leukaemia
- Hairy Cell Leukaemia
- Chronic Myelomonocytic Leukaemia
- Hodgkin Lymphoma
- Leukaemia
- Myelodysplastic Syndromes
- Non-Hodgkin Lymphoma
- Cervical Cancer
- Ovarian Cancer
- Germ Cell Ovarian Cancer
- Multiple Myeloma
- Various blood cancers and solid tumours
Sub-specialties:
- Medical Oncology
- Haemato-Oncology
- Bone Marrow Transplantation (BMT) / Stem Cell Therapy
- Gynaecological Oncology
- Infection Management in Cancer Patients
Advanced Procedures Performed:
- Bone Marrow Transplantation (BMT)
- Stem Cell Therapy
- Neoadjuvant Chemotherapy Protocols
- Targeted Therapy Implementation
- Complex Chemotherapy Protocols
- Infection Management in Immunocompromised Patients
Current Affiliations:
- Chairperson – Oncology & BMT, Artemis Hospitals, Gurugram
Academic & Research Roles:
- Former Professor and Head in the Department of Medical Oncology at AIIMS, New Delhi.
- Extensive involvement in medical education and training.
- Leadership in clinical research and protocol development.
- Pioneered cost-effective protocols for bone marrow and stem cell transplants.
Key Achievements & Contributions:
- Developed cost-effective treatment protocols for sustained bone marrow and stem cell transplantations.
- Visionary contributions to medical oncology in India.
- International recognition for oncology and BMT expertise.
National & International Awards:
- Padma Shri Award (2014) – One of India's highest civilian honours
- Dr. B.C. Roy Award (2008) – The premier medical award in India
- Indian Council of Medical Research (ICMR) Award
- Ranbaxy Science Foundation Award
Recognitions & Honours:
- Fellow of Indian Academy of Sciences (FASc)
- Fellow of National Academy of Medical Sciences of India (FAMS)
- Fellow of National Academy of Sciences (FNASI)
Co-Published Papers in Medical Journals:
- Respiratory Syncytial Virus Infection among Adults after Hematopoietic Stem Cell Transplantation (Aug 2022)
- Monoclonal Gammopathy of Renal Significance: Histomorphological Spectrum at a Tertiary Care Center (Aug 2022)
- Application of Bio-Active Elastin-like Polypeptide on Regulation of Human Mesenchymal Stem Cell Behavior (May 2022)
- Human metapneumovirus infection in haematopoietic stem cell transplant recipients: a case series (Mar 2021)
- Incidence of Respiratory Syncytial Virus Infection among Adults Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Study from India (Oct 2019)
- Challenges to Effective CC (Apr 2014)
- The Lancet Oncology Commission Challenges to effective cancer control in China, India, and Russia (Apr 2014)
- Challenges to effective cancer control in China, India, and Russia (Apr 2014)
Ongoing Clinical Trials Participation:
- Extensive research in haematological malignancies and gynaecological cancers.
- Development of innovative treatment protocols.
- International collaborations in oncology research.
- Continuous advancement in BMT and stem cell therapy techniques.
Notable Cases Handled:
Dr. Lalit Kumar has successfully managed numerous complex cases of haematological and gynaecological cancers, pioneering advanced and cost-effective BMT protocols. His dedication has led to significant improvements in patient outcomes, particularly in areas like multiple myeloma and chronic myeloid leukaemia.
Patient Testimonials:
"Dr. Lalit Kumar is an outstanding doctor. He explained my condition and treatment options with such clarity and compassion. I felt truly supported throughout my bone marrow transplant journey, and his expertise made all the difference to my recovery." - Priya S.
"Choosing Dr. Lalit Kumar for my mother's ovarian cancer treatment was the best decision. His knowledge of advanced chemotherapy and commitment to patient well-being is truly commendable. We are incredibly grateful for his care." - Rajesh M.
"As a patient seeking effective cancer treatment in India, I found Dr. Kumar to be exceptionally skilled. His team's coordination and his pioneering approach to making BMT affordable were life-changing for me. He is genuinely a top oncologist." - Anjali S.
Patient-Centred Care: Dr. Lalit Kumar's philosophy is rooted in providing comprehensive, compassionate, and patient-centred care. He believes in developing personalised treatment plans that consider each patient's unique needs, aiming for the best possible outcomes while prioritising their quality of life. His focus extends to making advanced treatments like BMT more accessible and cost-effective.
Technology & Innovation: Dr. Kumar is at the forefront of adopting advanced medical technologies and innovative treatment strategies in oncology. He continuously strives to integrate the latest research and clinical advancements into his practice, from pioneering stem cell therapy to implementing cutting-edge chemotherapy protocols and targeted therapies, ensuring his patients receive the most effective and modern care available.
| Treatment Type | Estimated Cost in INR | Estimated Cost in USD |
| Bone Marrow Transplant (BMT) | ₹15,00,000 - ₹30,00,000 | $18,000 - $36,000 |
| Chemotherapy Cycle | ₹50,000 - ₹2,00,000 | $600 - $2,400 |
| Targeted Therapy (per session/cycle) | ₹1,00,000 - ₹5,00,000 | $1,200 - $6,000 |
| Ovarian Cancer Treatment | ₹5,00,000 - ₹15,00,000 | $6,000 - $18,000 |
| Blood Cancer Treatment | ₹8,00,000 - ₹25,00,000 | $9,600 - $30,000 |
For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.
Language Support: The Cancer Rounds team typically offers support for international patients, including language services to ensure clear communication throughout the treatment journey.
Visa & Travel Assistance: The Cancer Rounds team assists with visa processes, travel arrangements, airport transfers, and accommodation, ensuring a smooth and stress-free experience for international patients.
Pre-treatment Virtual Consultations: Telemedicine capabilities are available for initial discussions, review of medical records, and second opinions, allowing international patients to consult with Dr. Lalit Kumar before travelling to India.
Fortis Hospital Gurgaon - India
Cervical Cancer
